Papers authored by Sutherland MK

Collect these papers and discover other ones on Labmeeting. Learn more.
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers.
+ cite this
+ View Abstract
Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, Zabinski RF, Sutherland MK, Gerber HP, Van Orden KL, Moore PA, Ruben SM, and Carter PJ
British journal of cancer 99(1):100, 2008 Jul 8 - Who cited this? | PubMed ID: 18542072 | Fulltext
Recommend
Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.
+ cite this
+ View Abstract
Rao LG, Murray TM, Wylie JN, McBroom RJ, and Sutherland MK
Journal of endocrinological investigation 28(10):919-27, 2005 Nov - Who cited this? | PubMed ID: 16419495 | Fulltext
Recommend
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.
+ cite this
+ View Abstract
Sutherland MK, Geoghegan JC, Yu C, Turcott E, Skonier JE, Winkler DG, and Latham JA
Bone 35(4):828-35, 2004 Oct - Who cited this? | PubMed ID: 15454089 | Fulltext
Recommend
Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex.
+ cite this
+ View Abstract
Winkler DG, Yu C, Geoghegan JC, Ojala EW, Skonier JE, Shpektor D, Sutherland MK, and Latham JA
The Journal of biological chemistry 279(35):36293, 2004 Aug 27 - Who cited this? | PubMed ID: 15199066 | Fulltext
Recommend
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts.
+ cite this
+ View Abstract
Sutherland MK, Geoghegan JC, Yu C, Winkler DG, and Latham JA
Bone 35(2):448-54, 2004 Aug - Who cited this? | PubMed ID: 15268896 | Fulltext
Recommend
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.
+ cite this
+ View Abstract
Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, and Latham JA
The EMBO journal 22(23):6267, 2003 Dec 1 - Who cited this? | PubMed ID: 14633986 | Fulltext
Recommend
Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
+ cite this
+ View Abstract
Sutherland MK, Brady H, Gayo-Fung LM, Leisten J, Lipps SG, McKie JA, O'Leary E, Patnaik N, Anderson DW, Bhagwat SS, and Stein B
Calcified tissue international 72(6):710-6, 2003 Jun - Who cited this? | PubMed ID: 14563000 | Fulltext
Recommend
Differential response of estrogen receptors alpha and beta to SP500263, a novel potent selective estrogen receptor modulator.
+ cite this
+ View Abstract
Brady H, Doubleday M, Gayo-Fung LM, Hickman M, Khammungkhune S, Kois A, Lipps S, Pierce S, Richard N, Shevlin G, Sutherland MK, Anderson DW, Bhagwat SS, and Stein B
Molecular pharmacology 61(3):562-8, 2002 Mar - Who cited this? | PubMed ID: 11854436 | Fulltext
Recommend
Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft models.
+ cite this
+ View Abstract
Brady H, Desai S, Gayo-Fung LM, Khammungkhune S, McKie JA, O'Leary E, Pascasio L, Sutherland MK, Anderson DW, Bhagwat SS, and Stein B
Cancer research 62(5):1439-42, 2002 Mar 1 - Who cited this? | PubMed ID: 11888917 | Fulltext
Recommend
The biological activities of 1alpha,25-dihydroxyvitamin D3 and its synthetic analog 1alpha,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation.
+ cite this
+ View Abstract
Rao LG, Liu LJ, Rawlins MR, McBroom RJ, Murray TM, Reddy GS, Uskokovic MR, Rao DS, and Sutherland MK
Biological & pharmaceutical bulletin 24(3):242-8, 2001 Mar - Who cited this? | PubMed ID: 11256478 | Fulltext
Recommend
Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol.
+ cite this
+ View Abstract
Rao LG, Sutherland MK, Reddy GS, Siu-Caldera ML, Uskokovic MR, and Murray TM
Bone 19(6):621-7, 1996 Dec - Who cited this? | PubMed ID: 8968029 | Fulltext
Recommend
Immunohistochemical localization of the estrogen receptor in human osteoblastic SaOS-2 cells: association of receptor levels with alkaline phosphatase activity.
+ cite this
+ View Abstract
Sutherland MK, Hui DU, Rao LG, Wylie JN, and Murray TM
Bone 18(4):361-9, 1996 Apr - Who cited this? | PubMed ID: 8726395 | Fulltext
Recommend
Carboxyl-terminal parathyroid hormone peptide (53-84) elevates alkaline phosphatase and osteocalcin mRNA levels in SaOS-2 cells.
+ cite this
+ View Abstract
Sutherland MK, Rao LG, Wylie JN, Gupta A, Ly H, Sodek J, and Murray TM
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 9(4):453-8, 1994 Apr - Who cited this? | PubMed ID: 8030432 | Fulltext
Recommend
Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus.
+ cite this
+ View Abstract
Sutherland MK, Wong L, Somerville MJ, Yoong LK, Bergeron C, Parmentier M, and McLachlan DR
Brain research. Molecular brain research 18(1-2):32-42, 1993 Apr - Who cited this? | PubMed ID: 8479289 | Fulltext
Recommend
Aluminum-binding serum proteins: desferrioxamine alters serum aluminum speciation.
+ cite this
+ View Abstract
Favarato M, Mizzen CA, Sutherland MK, Krishnan B, Kruck TP, and McLachlan DR
Clinica chimica acta; international journal of clinical chemistry 207(1-2):41-55, 1992 Apr 30 - Who cited this? | PubMed ID: 1591866 | Fulltext
Recommend
Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels.
+ cite this
+ View Abstract
Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, and McLachlan DR
Brain research. Molecular brain research 13(3):239-50, 1992 Apr - Who cited this? | PubMed ID: 1317496 | Fulltext
Recommend
Reduction of thyroid hormone receptor c-ERB A alpha mRNA levels in the hippocampus of Alzheimer as compared to Huntington brain.
+ cite this
+ View Abstract
Sutherland MK, Wong L, Somerville MJ, Handley P, Yoong L, Bergeron C, and McLachlan DR
Neurobiology of aging 13(2):301-12, 1992 - Who cited this? | PubMed ID: 1387923 | Fulltext
Recommend
Anomalous gene expression in Alzheimer disease: cause or effect.
+ cite this
+ View Abstract
McLachlan DR, Lukiw WJ, Mizzen C, Percy ME, Somerville MJ, Sutherland MK, and Wong L
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 18(3 Suppl):414-8, 1991 Aug - Who cited this? | PubMed ID: 1933691 | Fulltext
Recommend
A correlation between gene transcriptional activity and cerebral glucose metabolism in Alzheimer's disease-affected neocortex: cause or effect?.
+ cite this
+ View Abstract
Lukiw WJ, Handley P, Sutherland MK, Wong L, and McLachlan DR
Advances in experimental medicine and biology 291:249-56, 1991 - Who cited this? | PubMed ID: 1927687 | Fulltext
Recommend



Search Google Scholar for Sutherland MK

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.


Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!